Share your coffee stories with us by writing to info@comunicaffe.com.
LOS ANGELES, CA, USA – Vivi Labs officially debuts Vivi, the world’s first Longevity Coffee, supported by an oversubscribed pre-seed round backed by experienced operators, executives, athletes, and medical professionals. Coffee is a more than $500 billion global category.
At the same time, beauty, wellness, and supplements continue to scale as consumers prioritize longevity, energy, skin health, and performance. With the rise of AI, wearables, and at-home diagnostics, health is becoming measurable, personalized, and data driven. Vivi was built for this shift.
Despite category growth, most wellness solutions still fail at the behavioral level. Supplements are forgotten. Powders go unused. Nutrition feels fragmented, complex, and hard to sustain.
Vivi was built to solve that problem.
Vivi integrates science backed longevity ingredients directly into premium coffee, transforming the most consistent daily ritual into a simple, repeatable investment in long term health. The company’s formulations today are designed to support cellular function, collagen synthesis, and sustained energy without requiring changes to how people already live.
Vivi launches today direct to consumer at Vivilabs.com with two SKUs: Classic Black Coffee, designed to be strong, sharp, and direct, and Latte, a lightly sweetened offering designed to be mixed with frothed milk, activating the functional ingredients as part of a familiar café style experience. The company is currently developing a Ceremonial Grade Longevity Matcha, expected to launch in Q1 2026.
In addition to DTC, Vivi is launching with a curated retail footprint across Southern California, Florida, and New York, with plans to expand aggressively throughout 2026.
“Our view is simple. No one should feel stressed or overwhelmed by something that is good for you.” said Stefan Hertzberg, Co Founder and CEO of Vivi Labs. “We believe it should live in one delicious cup you already reach for every day. Vivi is about simplifying wellness while making it more effective, more personal, and easier to stay consistent with.”
Vivi’s products were developed over more than 16 months in collaboration with leading formulation partners, best in class ingredient suppliers, and a Medical Advisory Board. The company invested heavily in research, sourcing, and stability testing to ensure efficacy, safety, and scalability prior to launch.
“We are aggressively investing in R&D and product innovation,” Hertzberg added. “We have several first of their kind launches coming soon. This is not a single product company. We are building a long term platform around personalized health and longevity.”
The company’s initial investment round was oversubscribed, reflecting strong investor conviction in both the size of the opportunity and Vivi’s disciplined approach to category creation. Capital will be used to expand research, grow the Medical Advisory Board, accelerate product development, and support domestic and international expansion.
Vivi is building a global brand at the intersection of beauty, beverage, and personalized wellness, designed for a world where health is measurable, daily, and proactive.
